Intensity-modulated Radiotherapy
7 clinical trials · Condition
◉ Watch Intensity-modulated Radiotherapy
| Record | Firm | Date |
|---|---|---|
| Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma （SPARE-02） (NCT05235100) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-09-01 |
| Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses (NCT05114707) | Sun Yat-sen University | 2021-04-16 |
| Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01） (NCT05167994) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2020-05-01 |
Track Intensity-modulated Radiotherapy automatically
Every clearance here is in the API, with alerts when new ones post.